Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MBIO

Mustang Bio, Inc.

Healthcare · USD

Set alert

Price alert · MBIO

All alert types
0.40 USD +0.01 +1.94%
As of Oct 30, 2026 Extended hours 0.39 -2.00%
Bid
0.40 × 2
Ask
0.42 × 2
0.39 Day range 0.427
0.36 52-week range 1.46
YTD
-59.22%
1 year
-72.60%
Open
0.3932
Prev close
0.3925
Mkt cap
3.03M
Vol
48.29K
Avg vol
30.65K
EPS
-0.44
P/E
0.00
Div yield
0.00%
More statistics
Low
0.39
High
0.427
Forward P/E
-0.47
Beta
0.00
Short ratio
0.22
Inst. own
5.72%
Dividend
0.00
Ex-div date
50-d avg
0.22622
200-d avg
0.369385
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MBIO has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-35.78 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -2.5×
FY 2016: -1015×FY 2017: -484×FY 2018: -129×FY 2019: -153×FY 2020: -166×FY 2021: -109×FY 2022: -26.3×FY 2023: -11.3×FY 2024: -3.4×FY 2025: -2.5×
FY 2016 5y median -11.3× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.5×
FY 2016: 529×FY 2017: 253×FY 2018: 109×FY 2019: 142×FY 2020: 101×FY 2021: 64.9×FY 2022: 44.1×FY 2023: 4722×FY 2024: -14.0×FY 2025: 0.5×
FY 2016 5y median 44.1× FY 2025
P/FCF -0.9×
FY 2016: -3113×FY 2017: -961×FY 2018: -146×FY 2019: -197×FY 2020: -238×FY 2021: -124×FY 2022: -30.0×FY 2023: -11.7×FY 2024: -4.8×FY 2025: -0.9×
FY 2016 5y median -11.7× FY 2025
EV/EBITDA 6.6×
FY 2016: -1115×FY 2017: -483×FY 2018: -131×FY 2019: -169×FY 2020: -181×FY 2021: -112×FY 2022: -28.1×FY 2023: -12.0×FY 2024: -3.2×FY 2025: 6.6×
FY 2016 5y median -12.0× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -109.3%
FY 2016: -0.0%FY 2017: -0.1%FY 2018: -0.7%FY 2019: -0.5%FY 2020: -0.4%FY 2021: -0.8%FY 2022: -3.3%FY 2023: -8.5%FY 2024: -21.0%FY 2025: -109.3%
FY 2016 5y median -8.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -20.2%
FY 2016: -52.1%FY 2017: -52.3%FY 2018: -84.2%FY 2019: -93.2%FY 2020: -61.0%FY 2021: -59.0%FY 2022: -167.5%FY 2023: -41952.8%FY 2024: 406.7%FY 2025: -20.2%
FY 2016 5y median -59.0% FY 2025
ROIC -25.1%
FY 2016: 46.2%FY 2017: -53.1%FY 2018: -84.1%FY 2019: -68.3%FY 2020: -56.4%FY 2021: -58.2%FY 2022: -97.7%FY 2023: -1754.6%FY 2024: 571.0%FY 2025: -25.1%
FY 2016 5y median -58.2% FY 2025
ROA -10.9%
FY 2016: -46.0%FY 2017: -49.3%FY 2018: -71.7%FY 2019: -65.6%FY 2020: -54.6%FY 2021: -53.0%FY 2022: -83.9%FY 2023: -290.8%FY 2024: -169.2%FY 2025: -10.9%
FY 2016 5y median -83.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 85.0%
FY 2016: 364.4%FY 2017: -379.7%FY 2018: 1.8%FY 2019: -47.0%FY 2020: -23.8%FY 2021: -17.5%FY 2022: -14.1%FY 2023: 33.4%FY 2024: 68.0%FY 2025: 85.0%
FY 2016 FY 2025
EPS (diluted) 84.8%
FY 2016: -8.1%FY 2017: -156.6%FY 2018: 8.1%FY 2019: -17.3%FY 2020: 14.6%FY 2021: 33.3%FY 2022: 1.3%FY 2023: 46.7%FY 2024: 57.2%FY 2025: 84.8%
FY 2016 FY 2025
Free Cash Flow 53.9%
FY 2016: -162.8%FY 2017: -281.4%FY 2018: -72.7%FY 2019: -37.1%FY 2020: -12.0%FY 2021: -41.5%FY 2022: -15.4%FY 2023: 27.2%FY 2024: 77.0%FY 2025: 53.9%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 8.5×FY 2017: 17.0×FY 2018: 6.3×FY 2019: 8.1×FY 2020: 10.5×FY 2021: 10.3×FY 2022: 5.2×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 2.2×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 2.2×
FY 2016: 8.5×FY 2017: 17.0×FY 2018: 6.3×FY 2019: 8.1×FY 2020: 10.5×FY 2021: 10.3×FY 2022: 5.2×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 2.2×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.7×FY 2023: 20.3×FY 2024: -0.2×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 9.2×
FY 2016: 2.4×FY 2017: 1.1×FY 2018: 0.5×FY 2019: 1.1×FY 2020: 1.8×FY 2021: 1.7×FY 2022: 0.6×FY 2023: 0.1×FY 2024: 0.4×FY 2025: 9.2×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: 9.9×FY 2017: -3973×FY 2018: -3903×FY 2019: -26.0×FY 2020: -14.5×FY 2021: -4448×FY 2022: -22.7×FY 2023: -38.6×FY 2024: 3249×FY 2025: 0.0×
FY 2016 5y median -22.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 1.1%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -3.9%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31